Dong Lu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Molecular Biology top 5%
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 8
- Ubiquitin and proteasome pathways 7
- RNA Interference and Gene Delivery 6
- Oncology 17
- HER2/EGFR in Cancer Research 5
- Co-authors
- Pentao Liu (7 shared papers)Elena Vigorito (4 shared papers)Rebecca Leyland (3 shared papers)Susan Kohlhaas (1 shared paper)Xinjie Lu (10 shared papers)Allan Bradley (3 shared papers)Lia S. Campos (5 shared papers)Vijay V. Kakkar (6 shared papers)
- Journals
- European Journal of Medicinal Chemistry (6 papers)ACS Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (3 papers)PLoS ONE (3 papers)Cancer Management and Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dong Lu
101 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 148
- Cancer Research 369
- Molecular Biology 1.8k
- Hepatology 166
- Immunology and Allergy 128
- Immunology 431
Countries citing papers authored by Dong Lu
This map shows the geographic impact of Dong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Lu more than expected).
Fields of papers citing papers by Dong Lu
This network shows the impact of papers produced by Dong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Lu. The network helps show where Dong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Dong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 307 | |
| 2 | 2010 | 278 | |
| 3 | 2013 | 262 | |
| 4 | 2011 | 204 | |
| 5 | 2018 | 190 | |
| 6 | 2010 | 188 | |
| 7 | 2013 | 179 | |
| 8 | 2020 | 165 | |
| 9 | 2014 | 76 | |
| 10 | 2012 | 64 | |
| 11 | 2022 | 62 | |
| 12 | 2015 | 50 | |
| 13 | 2008 | 42 | |
| 14 | 2016 | 42 | |
| 15 | 2017 | 42 | |
| 16 | 2008 | 40 | |
| 17 | The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. | 2008 | 40 |
| 18 | 2015 | 39 | |
| 19 | 2022 | 38 | |
| 20 | 2013 | 37 |
About Dong Lu
Dong Lu is a scholar working on Molecular Biology, Oncology, Hepatology, Computational Theory and Mathematics and Cancer Research, having authored 102 papers that have together received 3.3k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Cell Adhesion Molecules Research (8 papers), Protein Degradation and Inhibitors (8 papers), Ubiquitin and proteasome pathways (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), RNA Interference and Gene Delivery (6 papers), MicroRNA in disease regulation (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (369 citations), Molecular Biology (1.8k citations), Hepatology (166 citations), Immunology and Allergy (128 citations) and Immunology (431 citations). Dong Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Pentao Liu, Elena Vigorito, Rebecca Leyland, Susan Kohlhaas, Xinjie Lu, Allan Bradley, Lia S. Campos, Vijay V. Kakkar, Xiaozhong Wang and Chengyi Lin. Their work appears in journals such as European Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Journal of Medicinal Chemistry, PLoS ONE and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.